Mark Gill

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Louie Stan Gee; Sclar David Alexander; Gill Mark Anthony
Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
Chin Alfred; Liu Shanshan; Ting-Chan Jennifer; Gill Mark A
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Gill Mark A; Kislik Alice Z; Gore Lana; Chandna Angela
Stability of advanced life support drugs in the field.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mark Gill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2005: Louie Stan Gee; Sclar David Alexander; Gill Mark Anthony
Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
The Annals of pharmacotherapy 2005;39(11):1861-9.
2005: Chin Alfred; Liu Shanshan; Ting-Chan Jennifer; Gill Mark A
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2005;62(10):1073-4.
2004: Gill Mark A; Kislik Alice Z; Gore Lana; Chandna Angela
Stability of advanced life support drugs in the field.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2004;61(6):597-602.
2004: Belzberg Howard; Zhu Jay; Cornwell Edward E; Murray James A; Sava Jack; Salim Ali; Velmahos George C; Gill Mark A
Imipenem levels are not predictable in the critically ill patient.
The Journal of trauma 2004;56(1):111-7.
2004: Han Emily E; Beringer Paul M; Louie Stan G; Gill Mark A; Shapiro Bertrand J
Pharmacokinetics of Ibuprofen in children with cystic fibrosis.
Clinical pharmacokinetics 2004;43(3):145-56.
2003: Williams Bradley R; Nazarians Arlette; Gill Mark A
A review of rivastigmine: a reversible cholinesterase inhibitor.
Clinical therapeutics 2003;25(6):1634-53.
2003: Sprauten Pål F; Beringer Paul M; Louie Stan G; Synold Timothy W; Gill Mark A
Stability and antibacterial activity of cefepime during continuous infusion.
Antimicrobial agents and chemotherapy 2003;47(6):1991-4.
2002: Nguyen Thao; Louie Stan G; Beringer Paul M; Gill Mark A
Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease.
Current opinion in pulmonary medicine 2002;8(6):521-8.
2001: Montgomery M J; Beringer P M; Aminimanizani A; Louie S G; Shapiro B J; Jelliffe R; Gill M A
Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
Antimicrobial agents and chemotherapy 2001;45(12):3468-73.
2000: Montgomery M J; Beringer P M; Louie S G; Gill M A
Estimation of creatinine clearance in patients with metastatic ovarian cancer.
Therapeutic drug monitoring 2000;22(6):695-700.
2000: Louie S; Chin A; Gill M A
Activity of dalteparin sodium in polypropylene syringes.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2000;57(8):760-2.
2000: Peters B P; Weissman F G; Gill M A
Pathophysiology and treatment of psoriasis.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2000;57(7):645-59; quiz 660-1.
1999: Nii L J; Chin A; Cao T M; Gill M A
Stability of sumatriptan succinate in polypropylene syringes.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1999;56(10):983-5.
1997: Cornwell E E; Belzberg H; Berne T V; Gill M A; Theodorou D; Kern J W; Yu W; Asensio J; Demetriades D
Pharmacokinetics of aztreonam in critically ill surgical patients.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1997;54(5):537-40.
1997: Moon Y S; Chung K C; Gill M A
Pharmacokinetics of meropenem in animals, healthy volunteers, and patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24 Suppl 2():S249-55.
1997: Nichol M B; Margolies J E; Gill M A
Factors associated with antihypertensive prescribing.
The Annals of pharmacotherapy 1997;31(2):154-9.
1996: Chin A; Moon Y S; Chung K C; Gill M A
Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1996;53(10):1174-6.
1996: Berne T V; Yellin A E; Appleman M D; Heseltine P N; Gill M A
Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis.
Journal of the American College of Surgeons 1996;182(5):403-7.
1995: Park T W; Le-Bui L P; Chung K C; Rho J P; Gill M A
Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(18):2022-4.
1995: Chung K C; Moon Y S; Chin A; Ulrich R W; Gill M A
Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(14):1554-6.
1995: Chung K C; Chin A; Gill M A
Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(14):1541-3.
1995: Jhee S S; Kern J W; Burm J P; Yellin A E; Gill M A
Piperacillin-tazobactam pharmacokinetics in patients with intraabdominal infections.
Pharmacotherapy 1995;15(4):472-8.
1995: Moon Y S; Chung K C; Chin A; Gill M A
Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1995;52(9):999-1001.
1995: Jhee S S; Gill M A; Yellin A E; Berne T V; Heseltine P N; Appleman M D
Pharmacoeconomics of piperacillin/tazobactam and imipenem/cilastatin in the treatment of patients with intra-abdominal infections.
Clinical therapeutics 1995;17(1):126-35.
1994: Burm J P; Choi J S; Jhee S S; Chin A; Ulrich R W; Gill M A
Stability of paclitaxel and fluconazole during simulated Y-site administration.
American journal of hospital pharmacy 1994;51(21):2704-6.
1994: Jhee S S; Burm J P; Gill M A
Comparison of aminoglycoside pharmacokinetics in Asian, Hispanic, and Caucasian patients by using population pharmacokinetic methods.
Antimicrobial agents and chemotherapy 1994;38(9):2073-7.
1994: Choi J S; Burm J P; Jhee S S; Chin A; Ulrich R W; Gill M A
Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
American journal of hospital pharmacy 1994;51(18):2273-6.
1994: Burm J P; Jhee S S; Chin A; Moon Y S; Jeong E; Nii L; Fox J L; Gill M A
Stability of paclitaxel with ondansetron hydrochloride or ranitidine hydrochloride during simulated Y-site administration.
American journal of hospital pharmacy 1994;51(9):1201-4.
1994: Pompilio F M; Fox J L; Inagaki K; Burm J P; Jhee S; Gill M A
Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
American journal of hospital pharmacy 1994;51(3):391-4.
1994: Okamoto M P; Nakahiro R K; Chin A; Bedikian A; Gill M A
Cefepime: a new fourth-generation cephalosporin.
American journal of hospital pharmacy 1994;51(4):463-77; quiz 541-2.
1994: Bedikian A; Okamoto M P; Nakahiro R K; Farino J; Heseltine P N; Appleman M D; Yellin A E; Berne T V; Gill M A
Pharmacokinetics of meropenem in patients with intra-abdominal infections.
Antimicrobial agents and chemotherapy 1994;38(1):151-4.
1993: Sclar D A; Skaer T L; Robison L M; Chin A; Okamoto M P; Nakahiro R K; Gill M A
Effect of antihypertensive formulation on health service expenditures.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1993;3(6):363-8.
1993: Jhee S S; Jeong E W; Chin A; Inagaki K; Fox J L; Gill M A
Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4 degrees C.
American journal of hospital pharmacy 1993;50(9):1918-20.
1993: Skaer T L; Sclar D A; Robison L M; Chin A; Gill M A; Okamoto M P; Nakahiro R K
Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization.
Clinical therapeutics 1993;15(4):715-25; discussion 714.
1993: Inagaki K; Takagi J; Lor E; Lee K J; Nii L; Gill M A
Stability of fluconazole in commonly used intravenous antibiotic solutions.
American journal of hospital pharmacy 1993;50(6):1206-8.
1993: Bedikian A; Gill M A
Impact of triplicate prescribing programme on psychotropic prescribing.
PharmacoEconomics 1993;3(2):172-3.
1993: Okamoto M P; Gill M A; Nakahiro R K; Bedikian A; Chin A; Yellin A E; Berne T V; Knupp C A
Cefepime pharmacokinetics in patients with acute cholecystitis undergoing cholecystectomy.
Clinical pharmacy 1993;12(2):134-7.
1993: Inagaki K; Gill M A; Okamoto M P; Takagi J
Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
Journal of parenteral science and technology : a publication of the Parenteral Drug Association 1993;47(1):35-9.
1993: Yellin A E; Berne T V; Appleman M D; Heseltine P N; Gill M A; Okamoto M P; Baker F J; Holcomb C
A randomized study of cefepime versus the combination of gentamicin and mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis.
Surgery, gynecology & obstetrics 1993;177 Suppl():23-9; discussion 35-40.
1993: Berne T V; Yellin A E; Appleman M D; Heseltine P N; Gill M A
A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis.
Surgery, gynecology & obstetrics 1993;177 Suppl():18-22; discussion 35-40.
1992: Inagaki K; Gill M A; Okamoto M P; Takagi J
Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.
American journal of hospital pharmacy 1992;49(11):2769-72.
1992: Inagaki K; Takagi J; Lor E; Okamoto M P; Gill M A
Determination of fluconazole in human serum by solid-phase extraction and reversed-phase high-performance liquid chromatography.
Therapeutic drug monitoring 1992;14(4):306-11.
1992: Okamoto M P; Gill M A; Nakahiro R K; Chin A; Yellin A E; Berne T V; Sclar D A; Knupp C A; Heseltine P N; Appleman M D
Tissue concentrations of cefepime in acute cholecystitis patients.
Therapeutic drug monitoring 1992;14(3):220-5.
1992: Gill M A; Okamoto M P; Nakahiro R K; Chin A; Inagaki K; Sclar D A
Pharmacokinetic population parameters for aminoglycosides in cholecystitis patients.
Therapeutic drug monitoring 1992;14(2):107-11.
1991: Nakahiro R K; Okamoto M P; Chin A; Gill M A; Chae J S; Sclar D A
Use of gentamicin clearance in estimating renal function.
Clinical pharmacy 1991;10(12):931-4.
1991: Sclar D A; Chin A; Skaer T L; Okamoto M P; Nakahiro R K; Gill M A
Effect of health education in promoting prescription refill compliance among patients with hypertension.
Clinical therapeutics 1991;13(4):489-95.
1991: Sclar D A; Skaer T L; Chin A; Okamoto M P; Gill M A
Utility of a transdermal delivery system for antihypertensive therapy. Part 2.
The American journal of medicine 1991;91(1A):57S-60S.
1991: Sclar D A; Skaer T L; Chin A; Okamoto M P; Gill M A
Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
The American journal of medicine 1991;91(1A):50S-56S.
1991: Sclar D A; Skaer T L; Chin A; Okamoto M P; Nakahiro R K; Gill M A
Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma.
Clinical therapeutics 1991;13(3):396-400.
1991: Yellin A E; Heseltine P N; Berne T V; Appleman M D; Gill M A; Chenella F C
Intramuscular imipenem as adjuvant therapy for acute cholecystitis and perforated or gangrenous appendicitis.
Chemotherapy 1991;37 Suppl 2():37-43.
1991: Okamoto M P; Chin A; Gill M A; Yellin A E; Berne T V; Heseltine P N; Appleman M D; Knupp C A; Sclar D A
Analysis of cefepime tissue penetration into human appendix.
Pharmacotherapy 1991;11(5):353-8.
1990: Chin A; Okamoto M P; Gill M A; Sclar D A; Berne T V; Yellin A E; Heseltine P N; Appleman M D
Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.
Antimicrobial agents and chemotherapy 1990;34(12):2354-7.
1990: Okamoto M P; Chin A; Gill M A; Yellin A E; Berne T V; Heseltine P N; Appleman M D
Comparison of two microcomputer Bayesian pharmacokinetic programs for predicting serum gentamicin concentrations.
Clinical pharmacy 1990;9(9):708-11.
1990: Chin A; Gill M A; Ito M K; Yellin A E; Berne T V; Heseltine P N; Appleman M D
Treatment of intra-abdominal infections: cost comparison of ampicillin/sulbactam and clindamycin/gentamicin.
Hospital formulary 1990;25(3):295-6, 303-5.
1990: Berne T V; Yellin A E; Appleman M D; Gill M A; Chenella F C; Heseltine P N
Controlled comparison of cefmetazole with cefoxitin for prophylaxis in elective cholecystectomy.
Surgery, gynecology & obstetrics 1990;170(2):137-40.
1989: Chin A; Gill M A; Ito M K; Yellin A E; Berne T V; Heseltine P N; Appleman M D
Cost analysis of two clindamycin dosing regimens.
DICP : the annals of pharmacotherapy 1989;23(12):980-3.
1989: Chin A; Gill M A; Ito M K; Yellin A E; Berne T V; Heseltine P N; Appleman M D
A cost comparison of intramuscular versus intravenous imipenem.
Hospital pharmacy 1989;24(11):905-9.
1989: Chin A; Gill M A; Ito M K; Yellin A E; Berne T V; Heseltine P N; Appleman M D; Chenella F C
Evaluation of two different dosage regimens of clindamycin and the penetration into human appendix.
Therapeutic drug monitoring 1989;11(4):421-4.
1988: Ito M K; Gill M A; Chenella F C; Berne T V; Yellin A E; Heseltine P N; Appleman M D
Intraoperative serum, bile, and gallbladder-wall concentrations of cefmetazole in patients undergoing cholecystectomy.
Clinical pharmacy 1988;7(6):467-8.
1988: Noguchi J K; Gill M A
Sulbactam: a beta-lactamase inhibitor.
Clinical pharmacy 1988;7(1):37-51.
1987: Hurst A K; Iseri K T; Gill M A; Noguchi J K; Gilman T M; Jelliffe R W
Comparison of four methods for predicting serum gentamicin concentrations in surgical patients with perforated or gangrenous appendicitis.
Clinical pharmacy 1987;6(3):234-8.
1987: Berne T V; Yellin A E; Appleman M D; Gill M A; Chenella F C; Heseltine P N
Surgically treated gangrenous or perforated appendicitis. A comparison of aztreonam and clindamycin versus gentamicin and clindamycin.
Annals of surgery 1987;205(2):133-7.
1986: Chenella F C; Klotz T A; Gill M A; Paulson Y J; Noguchi J K; Hurst A K; Robinson D C; Hill-Besinque K; Clifford C M; McGehee W G
Blood-sampling strategy for monitoring continuous intravenous heparin therapy.
Clinical pharmacy 1986;5(6):510-3.
1986: Heseltine P N; Berne T V; Yellin A E; Gill M A; Appleman M D
The efficacy of cefoxitin vs. clindamycin/gentamicin in surgically treated stab wounds of the bowel.
The Journal of trauma 1986;26(3):241-5.
1986: Gill M A; Chenella F C; Heseltine P N; Appleman M D; Yellin A E; Berne T V; Feldman M J; Sharon D
Cost analysis of antibiotics in the management of perforated or gangrenous appendicitis.
American journal of surgery 1986;151(2):200-4.
1986: Heseltine P N; Yellin A E; Appleman M D; Gill M A; Chenella F C; Berne T V; Leedom J M
Imipenem therapy for perforated and gangrenous appendicitis.
Surgery, gynecology & obstetrics 1986;162(1):43-8.
1986: Gill M A; Cheetham T C; Chenella F C; Heseltine P N; Yellin A E; Appleman M D; Berne T V
Matched case-control study of adjusted versus nonadjusted gentamicin dosing in perforated and gangrenous appendicitis.
Therapeutic drug monitoring 1986;8(4):451-6.
1985: Yellin A E; Heseltine P N; Berne T V; Appleman M D; Gill M A; Riggio C E; Chenella F C
The role of Pseudomonas species in patients treated with ampicillin and Sulbactam for gangrenous and perforated appendicitis.
Surgery, gynecology & obstetrics 1985;161(4):303-7.
1984: Gill M A; Cohen J L; Chenella F C; Hisayasu G H; Chandrasoma P; Warnecke G M; Chung H; Heseltine P N; Yellin A E; Berne T V
Gentamicin penetration into diseased appendix tissue.
Therapeutic drug monitoring 1984;6(3):298-301.
1984: Gill M A; Kern J W; Chenella F C; Heseltine P N; Yellin A E; Foulds G; Berne T V
Pharmacokinetics of parenteral sulbactam in patients with appendicitis.
Therapeutic drug monitoring 1984;6(4):428-31.
1983: Chenella F C; Klotz T A; Gill M A; Kern J W; McGhan W F; Paulson Y J; Schuttenhelm K M; Cheetham T C; Noguchi J K; McGehee W G
Comparison of physician and pharmacist management of anticoagulant therapy of inpatients.
American journal of hospital pharmacy 1983;40(10):1642-5.
1983: Heseltine P N; Yellin A E; Appleman M D; Gill M A; Chenella F C; Kern J W; Berne T V
Perforated and gangrenous appendicitis: an analysis of antibiotic failures.
The Journal of infectious diseases 1983;148(2):322-9.
1983: Torres M J; Kern J W; Gill M A; Berne T V; Heseltine P N; Yellin A E; Chenella F C
Comparison of serum sampling methods for estimating gentamicin pharmacokinetic variables.
Clinical pharmacy 1983;2(4):353-5.
1983: Gill M A; Kern J W; Chenella F C; Berne T V; Heseltine P N; Yellin A E
Influence of manufacturer lot number on pharmacokinetic manipulation of gentamicin serum concentrations.
Therapeutic drug monitoring 1983;5(4):419-22.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Mark Gill

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Mark Gill (preview)

All Publications